Art. 117 Directive (EU) 2001/83

In forcesince 20 Jan 2011cited 12×
1.

Without prejudice to the measures provided for in Article 116, Member States shall take all appropriate steps to ensure that the supply of the medicinal product is prohibited and the medicinal product withdrawn from the market, if the view is taken that:

(a)

the medicinal product is harmful; or

(b)

it lacks therapeutic efficacy; or

(c)

the risk-benefit balance is not favourable; or

(d)

its qualitative and quantitative composition is not as declared; or

(e)

the controls on the medicinal product and/or on the ingredients and the controls at an intermediate stage of the manufacturing process have not been carried out or if some other requirement or obligation relating to the grant of the manufacturing authorisation has not been fulfilled.

2.

The competent authority may limit the prohibition to supply the product, or its withdrawal from the market, to those batches which are the subject of dispute.

3.

The competent authority may, for a medicinal product for which the supply has been prohibited or which has been withdrawn from the market in accordance with paragraphs 1 and 2, in exceptional circumstances during a transitional period allow the supply of the medicinal product to patients who are already being treated with the medicinal product.

The 10 that are cited most themselves, of 12.

  • Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 20…14bLaw

    … се основава на някое от основанията, установени в член 116 или в член 117, параграф 1 от Директива 2001/83/ЕО. 2. Титулярят на разрешение за …

  • Directive (EU) 2004/27Lawamends

  • Directive (EU) 2010/84Lawamends

  • Regulation (EU) No 1027/2012 of the European Parliament and of the Council of 25 October…1Law

    … се основава на някое от основанията, установени в член 116 или в член 117, параграф 1 от Директива 2001/83/ЕО. 2. Титулярят на разрешение за …

  • Arrêt du Tribunal (septième chambre) du 7 mars 2013. Acino AG (anciennement Acino Pharma GmbH) contre Commission européenne.Decision

    … eigene Erwägungen der Kommission nennt, aus denen erkennbar ist, dass diese ihr Ermessen ausgeübt hat, um in den Art. 116 und 117 der Richtlinie 2001/83 vorgesehene Maßnahmen zu erlassen. In der Tat hat die Kommission im zweiten …

    7 Mar 2013 · 62010TJ0539

  • Arzneimittelgesetz2175mLaw

    … Dabei sind auch die Gründe für diese Maßnahme anzugeben, insbesondere ob sie aus den in Art. 116 oder 117 Abs. 1 der Richtlinie 2001/83/EG genannten Gründen erfolgt. Bejahendenfalls ist auch die Agentur zu informieren. (3) Die Abs. 1 …

  • Judgment of the Court (Sixth Chamber), 10 April 2014. Acino AG v European Commission.Decision

    In the present case, the appeal seeks, in essence, to call into question the General Court’s assessment of the conditions for the application of Articles 116 and 117 of Directive 2001/83 in the light of the precautionary principle, as …

    10 Apr 2014 · 62013CJ0269

  • Order of the Vice-President of the Court of 29 April 2025. Advanz Pharma Ltd v European Commission.Decision

    Article 117(1)(b) of Directive 2001/83 provides: ‘… Member States shall take all appropriate steps to ensure that the supply of the medicinal product is prohibited and the medicinal product withdrawn from the market, if the view is …

    29 Apr 2025 · 62024CO0859

  • Opinion of Advocate General Medina delivered on 6 October 2022. European Commission and Others v Pharmaceutical Works Polpharma S.A.Decision

    I should point out that the framework applicable in 2013 to the renewal of the marketing authorisation of Fumaderm includes, for instance, Article 24 of Directive 2001/83, which establishes the obligation incumbent on the national …

    6 Oct 2022 · 62021CC0438

  • BVerfG, Beschluss vom 16. Dezember 2025 - 1 BvR 1863/23Decision

    … Mitgliedstaaten die Möglichkeit hätten, während eines Übergangszeitraums außerordentliche Maßnahmen nach Art. 117 Abs. 3 oder Art. 5 Abs. 1 der Richtlinie 2001/83/EG des Europäischen Parlaments und des Rates zu ergreifen.

    16 Dec 2025 · KVRE465032601